株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

POC心臓検査装置の世界市場:2019年~2023年

Global Cardiac POC Testing Devices Market 2019-2023

発行 TechNavio (Infiniti Research Ltd.) 商品コード 905963
出版日 ページ情報 英文 126 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.66円で換算しております。
Back to Top
POC心臓検査装置の世界市場:2019年~2023年 Global Cardiac POC Testing Devices Market 2019-2023
出版日: 2019年08月01日 ページ情報: 英文 126 Pages
概要

世界のPOC心臓検査装置市場は、循環器疾患(CVD)の高い発生率、糖尿病患者の増加、心臓マーカー検査規制当局への重点などが成長促進要因となり、予測期間中に6%以上のCAGRで拡大する見込みです。しかし、メーカーにとっての課題である製品のリコール、コレステロール値を測定する別の方法、発展途上国での診断検査への限られたアクセスなどが、予測期間中のPOC心臓検査装置業界の成長を妨げる可能性があります。

当レポートでは、世界のPOC心臓検査装置市場について調査分析し、市場規模および成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2018年)
  • 市場規模および予測(2018年~2023年)

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代用品の脅威
  • 競争相手の脅威
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場セグメンテーション:エンドユーザー別
  • エンドユーザー別比較:市場規模および予測(2018年~2023年)
  • 病院および研究所
  • 診断センター
  • 外来センターおよび医師の診療所
  • 市場機会:エンドユーザー別

第7章 顧客情勢

第8章 地域情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2018年~2023年)
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

  • ベンダーのオンラインプレゼンスの高まり
  • 診断の技術的進歩
  • ウェアラブルデバイスの出現

第12章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • bioMerieux SA
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Siemens Healthcare GmbH

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第15章 TECHNAVIOについて

図表
  • Exhibit 01: Product overview
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: End-user - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Hospitals and laboratories - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Hospitals and laboratories - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Diagnostic centers - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Diagnostic centers - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Ambulatory centers and physicians' clinics - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 25: Ambulatory centers and physicians' clinics - Year-over-year growth 2019-2023 (%)
  • Exhibit 26: Market opportunity by end-user
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2018-2023 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: Key leading countries
  • Exhibit 39: Market opportunity
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Abbott Laboratories - Vendor overview
  • Exhibit 47: Abbott Laboratories - Business segments
  • Exhibit 48: Abbott Laboratories - Organizational developments
  • Exhibit 49: Abbott Laboratories - Geographic focus
  • Exhibit 50: Abbott Laboratories - Segment focus
  • Exhibit 51: Abbott Laboratories - Key offerings
  • Exhibit 52: bioMerieux SA - Vendor overview
  • Exhibit 53: bioMerieux SA - Product segments
  • Exhibit 54: bioMerieux SA - Organizational developments
  • Exhibit 55: bioMerieux SA - Geographic focus
  • Exhibit 56: bioMerieux SA - Key offerings
  • Exhibit 57: Danaher Corp. - Vendor overview
  • Exhibit 58: Danaher Corp. - Business segments
  • Exhibit 59: Danaher Corp. - Organizational developments
  • Exhibit 60: Danaher Corp. - Geographic focus
  • Exhibit 61: Danaher Corp. - Segment focus
  • Exhibit 62: Danaher Corp. - Key offerings
  • Exhibit 63: F. Hoffmann La Roche Ltd. - Vendor overview
  • Exhibit 64: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 65: F. Hoffmann La Roche Ltd. - Organizational developments
  • Exhibit 66: F. Hoffmann La Roche Ltd. - Geographic focus
  • Exhibit 67: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibit 68: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 69: Siemens Healthcare GmbH - Vendor overview
  • Exhibit 70: Siemens Healthcare GmbH - Business segments
  • Exhibit 71: Siemens Healthcare GmbH - Organizational developments
  • Exhibit 72: Siemens Healthcare GmbH - Geographic focus
  • Exhibit 73: Siemens Healthcare GmbH - Segment focus
  • Exhibit 74: Siemens Healthcare GmbH - Key offerings
  • Exhibit 75: Validation techniques employed for market sizing
  • Exhibit 76: Definition of market positioning of vendors
目次
Product Code: IRTNTR31801

About this market

Cardiac POC testing devices aid in the assessment of glucose and cholesterol levels in individuals, which in turn help the practitioners to identify the risk of developing thrombosis and cardiovascular diseases (CVDs) such as coronary artery disease (CAD), myocardial infarction and heart failure. Technavio's cardiac POC testing devices market analysis considers sales from hospitals and laboratories, diagnostic centers, and ambulatory centers and physicians' clinics. Our analysis also considers the sales of cardiac POC testing devices in Asia, Europe, North America, and ROW. In 2018, the hospitals and laboratories segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as High inflow of patients, expanding the use of medical devices, and growing healthcare expenditure will play a significant role in the hospitals and laboratories segment to maintain its market position. Also, our global cardiac POC testing devices market report also looks at factors such as high incidence of CVDs, growing diabetic population, emphasis on cardiac marker testing regulatory authorities. However, product recalls posing a challenge to manufacturers, alternative methods of measuring cholesterol levels, limited access to diagnostic tests in developing countries may hamper the growth of the cardiac POC testing devices industry over the forecast period.

Overview

High incidence of CVDs

Cardiovascular diseases (CVDs) are rising due to a high level of a sedentary lifestyle, smoking, alcohol consumption, high levels of cholesterol in the blood, and diabetes, and others. This has driven the demand for cardiac POC testing devices. Elevated cholesterol levels shoot up the blood pressure. Cardiac POC testing devices' ability to assess blood glucose and cholesterol levels rapidly has also increased its adoption rate. This demand will lead to the expansion of the global cardiac POC testing devices market at a CAGR of over 6% during the forecast period.

Technological advances in diagnostics

The global cardiac POC testing devices market has witnessed significant developments, owing to factors such as portability of devices, research centers moving to close patent locales, increasing test menus, and rising adoption of multiparameter monitoring devices. The implementation of laboratory functions into portable systems has led to a standard shift in the diagnostics field. Miniaturization of technology aids in the quantification of living cells on portable systems using small volumes of reagents. This has encouraged several hospitals and clinics across the world to switch from conventional testing methods to POC testing due to its improved efficiency and faster turnaround time. Sensors, microsystems, and low-cost imaging technologies have been developed for POC testing. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global cardiac POC testing devices market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of a few major players, the global cardiac POC testing devices market is moderately concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiac POC testing devices manufacturers, that include Abbott Laboratories, bioMerieux SA, Danaher Corp., F. Hoffmann La Roche Ltd., and Siemens Healthcare GmbH.

Also, the cardiac POC testing devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals and laboratories - Market size and forecast 2018-2023
  • Diagnostic centers - Market size and forecast 2018-2023
  • Ambulatory centers and physicians' clinics - Market size and forecast
  • 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Increasing online presence of vendors
  • Technological advances in diagnostics
  • Advent of wearable devices

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMerieux SA
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Siemens Healthcare GmbH

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Back to Top